Atsena Therapeutics Inc.
2 clinical trials · Sponsor
◉ Watch Atsena Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis (NCT05878860) | Atsena Therapeutics Inc. | 2023-08-22 |
| Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D (NCT03920007) | Atsena Therapeutics Inc. | 2019-10-22 |
Track Atsena Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.